Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQFinancialsInsurance - Property & CasualtySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.70 → 3.69 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for SLDE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain competitive position amid Florida market challenges | A supporting condition in Slide Insurance Holdings, Inc.'s published investment case. The stated target is No material loss of market share in Florida. | Intact | Significant market share loss or worsening competitive conditions in Florida | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a growth-focused insurer with a mixed execution record, rather than a steady, proven compounder. The 1-to-3-year thesis is intact: recent financial performance is strong, though underwriting results and management execution still need monitoring.
The evidence labels SLDE cheap, while also showing a 1.52 premium versus peers and a durable-premium valuation driver. The expectations gap is negative, which suggests market expectations may be ahead of the evidence; however, the priced-in assessment is tagged justified and fragility is low.
Near term, recent results show growth, with third-quarter revenue and gross premiums written above the prior-year period, and management raised its 2026 premium and net income outlooks. The accident-year loss ratio improved, but the reported combined ratio worsened because of higher catastrophe losses. Management execution is volatile, and a past deep miss plus downward-trending earnings surprises remain risks despite a low near-term miss estimate.
The multi-year case depends on sustaining diversified growth while meeting the raised 2026 outlook and keeping underwriting disciplined. A guidance cut would be a meaningful negative, while continued earnings strength at sector bellwethers could support Financials momentum. The evidence also flags rate cuts as a sector risk, since Financials are described as tending to do better when rates stay high.
For the next 1 to 3 years, SLDE’s strong growth and intact thesis are balanced by mixed underwriting signals, volatile execution, and sensitivity to guidance and sector conditions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Net income targets $455M-$470M, showing profit strength. |
| Intact |
| Net income falls below $455M in FY26 |
Net income: $138.23M FY2026-Q3; GAAP. Published target: >= $455M and <= $470M net income. Annual target cannot be compared with a quarterly or TTM observation. Oct 29, 2026138,230,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve $1.85B to $1.95B gross written premiums in 2026 | A primary condition in Slide Insurance Holdings, Inc.'s published investment case. The stated target is >= $1.85B and <= $1.95B in gross written premiums. | Intact | Gross written premiums fall below $1.85B or exceed $1.95B in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Implement $100M share buyback program | A supporting condition in Slide Insurance Holdings, Inc.'s published investment case. The stated target is Complete $100M buyback program. | Intact | Buyback program is canceled or materially delayed | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.52 → $3.69 · observed estimates
$1.54B → $1.78B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.52 | $1,543,930,400 | 5 / 2 |
| 2026-07-25 | $3.52 | $1,543,930,400 | 5 / 2 |
| 2026-07-26 | $3.52 | $1,543,930,400 | 5 / 2 |
| 2026-07-27 | $3.52 | $1,543,930,400 | 5 / 2 |
| 2026-07-28 | $3.52 | $1,543,930,400 | 5 / 2 |
| 2026-07-29 | $3.55 | $1,543,930,400 | 5 / 2 |
| 2026-07-30 | $3.55 | $1,543,930,400 | 5 / 2 |
| 2026-07-31 | $3.64 | $1,547,136,900 | 5 / 2 |
| 2026-08-01 | $3.63 | $1,695,018,948 | 3 / 2 |
| 2026-08-02 | $3.69 | $1,571,501,480 | 5 / 2 |
| 2026-08-03 | $3.63 | $1,695,018,948 | 3 / 2 |
| 2026-08-04 | $3.63 | $1,695,018,948 | 3 / 2 |
| 2026-08-05 | $3.63 | $1,695,018,948 | 3 / 2 |
| 2026-08-06 | $3.63 | $1,695,018,948 | 3 / 2 |
| 2026-08-08 | $3.69 | $1,562,367,660 | 5 / 3 |
| 2026-08-09 | $3.69 | $1,562,367,660 | 5 / 3 |
| 2026-08-10 | $3.69 | $1,562,367,660 | 5 / 3 |
| 2026-08-12 | $3.68 | $1,749,951,243 | 3 / 2 |
| 2026-08-13 | $3.68 | $1,749,951,243 | 3 / 2 |
| 2026-08-14 | $3.68 | $1,749,951,243 | 3 / 2 |
| 2026-08-15 | $3.68 | $1,749,951,243 | 3 / 2 |
| 2026-08-16 | $3.68 | $1,749,951,243 | 3 / 2 |
| 2026-08-17 | $3.68 | $1,749,951,243 | 3 / 2 |
| 2026-08-18 | $3.68 | $1,749,951,243 | 3 / 2 |
| 2026-08-19 | $3.68 | $1,749,951,243 | 3 / 2 |
| 2026-08-20 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-08-21 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-08-22 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-08-23 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-08-24 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-08-25 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-08-26 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-08-27 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-08-28 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-08-29 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-08-30 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-08-31 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-01 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-02 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-03 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-04 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-05 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-06 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-07 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-08 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-09 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-10 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-11 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-12 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-13 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-14 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-15 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-16 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-17 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-18 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-19 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-20 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-21 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-22 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-23 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-24 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-25 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-26 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-27 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-28 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-29 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-09-30 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-10-01 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-10-02 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-10-03 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-10-04 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-10-05 | $3.70 | $1,906,632,310 | 3 / 2 |
| 2026-10-06 | $3.69 | $1,765,661,893 | 3 / 2 |
| 2026-10-07 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-08 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-09 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-10 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-11 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-12 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-13 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-14 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-15 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-16 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-17 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-18 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-19 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-20 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-21 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-22 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-23 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-24 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-25 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-26 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-27 | $3.64 | $1,739,809,894 | 3 / 2 |
| 2026-10-28 | $3.65 | $1,739,809,894 | 3 / 2 |
| 2026-10-29 | $3.65 | $1,756,185,643 | 3 / 2 |
| 2026-10-30 | $3.65 | $1,756,185,643 | 3 / 2 |
| 2026-10-31 | $3.69 | $1,779,385,644 | 3 / 2 |
| 2026-11-01 | $3.69 | $1,779,385,644 | 3 / 2 |
| 2026-11-02 | $3.69 | $1,779,385,644 | 3 / 2 |
| 2026-11-03 | $3.69 | $1,779,385,644 | 3 / 2 |
| 2026-11-04 | $3.69 | $1,779,385,644 | 3 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 4 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 3 recorded
1 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.